Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Meléndez, María Manuela
DOB: 01-AUG-1982 (Age: 43)
Gender: female
ID: 3014-208609-6 (ECI)
Author
Mateos, Maricruz
Patient summary Document
European Patient Summary
Report Date: 08-JUN-2025

Problem list

Condition Onset Date / Period Status
Essential hypertension 17-Apr-2016 active
Chronic sinusitis 18-Dec-1983 active
Streptococcal sore throat 20-Aug-2023 - 02-Sep-2023 inactive
Viral sinusitis 21-Jan-2019 - 17-Feb-2019 inactive

Medication list

Medication Since Form Dosage Reason
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-06-08 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2025-06-08 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Chlorpheniramine maleate 2 mg and ibuprofen 200 mg and pseudoephedrine hydrochloride 30 mg oral tablet 1980-05-25 - 1 tablet (2 mg / 200 mg / 30 mg) every 4 to 6 hours as needed -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 08-Jun-2025
SARS-CoV-2 mRNA vaccine 01-Aug-2021
Hepatitis A virus antigen only vaccine product 10-May-2020
Clostridium tetani toxoid antigen adsorbed only vaccine product 10-May-2020

Procedure History list

No known procedures

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
Mold 1980-05-25 active environment Nasal discharge present (situation)
Latex 1980-05-25 active environment Wheal (finding)<br> </br>Eruption of skin (disorder)
Grass pollen 1980-05-25 active environment
House dust mite 1980-05-25 active environment
Animal dander 1980-05-25 active environment Rhinoconjunctivitis (disorder)<br> </br>Wheal (finding)
Wheat 1980-05-25 active food
Allergy to drug 1980-05-25 active environment
Fish 1980-05-25 active food Dyspnea (finding)<br> </br>Eruption of skin (disorder)
Tree pollen 1980-05-25 active environment

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 17-Apr-2016 Essential hypertension (disorder)
  • Achieve and maintain target blood pressure through lifestyle changes such as diet, exercise, and stress management.
Routine antenatal care 17-Apr-2005 -
Self-care interventions 05-May-1980 -

Vital Signs

Vital Signs 2025-06-08 2024-06-02
Body Height 163.2 cm 163.2 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} 2 {score}
Body Weight 74.8 kg 74.8 kg
Body mass index (BMI) [Ratio] 28.1 kg/m2 28.1 kg/m2
Heart rate 97 /min 77 /min
Respiratory rate 14 /min 13 /min
Blood pressure panel with all children optional 83 mm[Hg] 79 mm[Hg]

Relevant diagnostic tests/laboratory data

Recent Lab Observations 08-JUN-2025 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 173.3 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 141.5 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 83.8 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 61.2 H 40 - 60 mg/dL

Device Use

Device Date (since)
Home nebulizer (physical object) 18-Dec-1983